Human immunodeficiency virus (HIV) vaccines have the potential to improve antiretroviral drug treatment by inducing cytotoxic killing of HIV-infected cells. Prophylactic vaccines utilize new antigens… (More)
OBJECTIVE
Medical costs that may be avoided when any of the four new oral anticoagulants (NOACs), dabigatran, rivaroxaban, apixaban, and edoxaban, are used instead of warfarin for the treatment of… (More)
OBJECTIVE
This study evaluated differences in medical costs associated with clinical end-points from randomized clinical trials that compared the new oral anticoagulants (NOACs), dabigatran,… (More)
OBJECTIVE
To evaluate patient-reported reasons for discontinuing antimuscarinic prescription medications for overactive bladder (OAB).
PATIENTS AND METHODS
A phase 1 screening survey was sent to a… (More)
OBJECTIVE
To reconstitute immune responses capable of eliminating infected cells and suppressing viral load during chronic retroviral infection.
DESIGN
: A topical, DNA-based therapeutic… (More)
The Self-Assessment Goal Achievement (SAGA) questionnaire was developed to identify treatment goals and assess goal-achievement in patients with lower urinary tract symptoms (LUTS). This study… (More)
This study evaluated avoidances in medical costs associated with clinical endpoints from randomized clinical trials that evaluated the efficacy and safety of the new oral anticoagulants (NOACs),… (More)
BACKGROUND
Fesoterodine, a new once daily antimuscarinic, has proven to be an effective, safe, and well-tolerated treatment in patients with overactive bladder (OAB). To date, no analysis has… (More)
IL-7 and IL-15 are key cytokines involved in the generation and maintenance of memory CD8+ T-cells. We evaluated these cytokines as molecular adjuvants for topical HIV-1 DermaVir vaccine. We found… (More)
AIMS
To discuss the importance of patients' treatment goals and perceived goal attainment to better address expectations in the treatment of lower urinary tract symptoms (LUTS), including overactive… (More)